CytoDyn, Inc. (OTC: CYDY) NEXT SUPER STOCK investor conference presentation

August 21, 2019 admin Healthcare, Investor Presentations Comments Off on CytoDyn, Inc. (OTC: CYDY) NEXT SUPER STOCK investor conference presentation

CytoDyn, Inc. (OTC: CYDY)

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Next Super Stock investor conference presentation 8/15/2019




Related Articles

Healthcare

CytoDyn (OTC: CYDY) Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab

September 4, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab

VANCOUVER, Washington, Sept. 04, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the […]

Healthcare

CytoDyn (OTC: CYDY) to Present at RHK Capital 2019 Disruptive Growth Conference

August 29, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) to Present at RHK Capital 2019 Disruptive Growth Conference

VANCOUVER, Washington, Aug. 29, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]